Hutchison China MediTech has appointed Paul Rutherford Carter as its Senior Independent Non-Executive Director, and a member of several its committees.
He will be a member of Chi-Med’s Audit Committee, Remuneration Committee and Technical Committee of Chi-Med
Chi-Med has today been active in informing its shareholders about its endeavours. Earlier today the company announced launching two Phase two cancer drug studies in China.
In addition to all these news, it has also announced two resignations. Shigeru Endo tendered his resignation as Non-executive Director and Christopher Nash tendered his resignation as Senior Independent Non-executive Director and member of Audit Committee and Remuneration Committee. All the managerial changes are effective on February 1, 2017.
Seasoned life sciences expert brings further global portfolio management and financial expertise from 20 years at Merck & Co. Inc. to the PureTech board Ms. Barber-Lui will also become chair of the Audit Committee of the board BOSTON--(BUSINESS WIRE)--PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), a…
January 16, 2023 Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced an extraordinary general meeting of shareholders will be held at 12:00 PM CET on Monday, February 27, 2023 at…
MONTREAL, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced that Mr. Alain Trudeau has resigned from the Board of Directors of Theratechnologies and as a member of its…
